Acknowledgments
Breast Cancer
ONCOLOGY, MAY, BREAST CANCER, RECRUITMENT
The DATA study was funded by AstraZeneca. The funding source was involved in the design and monitoring of the DATA trial, but had no role in data collection, data analysis, data interpretation, and writing of the report. We would like to thank all treating physicians, trial site principal investigators, and local data managers who contributed to the recruitment, treatment, and follow-up of study participants. Part of the results of this study were presented at the European Society of Medical Oncology (ESMO) Breast Cancer 2023 Congress (May 11-13, 2023, Berlin, Germany). After the oral presentation, part of the results were discussed in two (video) interviews with, respectively, the 